Результати пошуку - Y‐P Liu

  • Показ 1 - 9 результатів із 9
Уточнити результати
  1. 1
    Cyclic 3':5'-nucleotide phosphodiesterase. Ca2+ confers more helical conformation to the protein activator.

    Cyclic 3':5'-nucleotide phosphodiesterase. Ca2+ confers more helical conformation to the protein activator. за авторством Y P Liu, Wai Yiu Cheung

    Опубліковано 1976
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    Prospect of extracellular vesicles in tumor immunotherapy

    Prospect of extracellular vesicles in tumor immunotherapy за авторством Wenbo Xia, Yunhan Tan, Y.-P. Liu, Na Xie, Huili Zhu

    Опубліковано 2025
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  3. 3
    A Robust Protocol for Using Multiplexed Droplet Digital PCR to Quantify Somatic Copy Number Alterations in Clinical Tissue Specimens

    A Robust Protocol for Using Multiplexed Droplet Digital PCR to Quantify Somatic Copy Number Alterations in Clinical Tissue Specimens за авторством Curtis Hughesman, Xian Lu, Kelly Y. P. Liu, Yuqi Zhu, Catherine F. Poh, Charles A. Haynes

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    Knee osteoarthritis: A review of animal models and intervention of traditional Chinese medicine

    Knee osteoarthritis: A review of animal models and intervention of traditional Chinese medicine за авторством Xuyu Song, Y P Liu, Si–Yi Chen, Lei Zhang, Huijie Zhang, Xianhui Shen, Hang Du, Rong Sun

    Опубліковано 2024
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  5. 5
    Arsenic: health effects, mechanisms of actions, and research issues.

    Arsenic: health effects, mechanisms of actions, and research issues. за авторством Charles O. Abernathy, Y P Liu, David G. Longfellow, H. Vasken Aposhian, B.D. Beck, Bruce A. Fowler, Robert A. Goyer, R. E. Menzer, Toby G. Rossman, Claudia Thompson, Michael P. Waalkes

    Опубліковано 1999
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78

    Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through th... за авторством H-Y Tsai, Y-F Yang, Alexander T.H. Wu, Chih‐Jen Yang, Y-P Liu, Yi‐Hua Jan, Chih‐Hsin Lee, Y-W Hsiao, C-T Yeh, Chia‐Ning Shen, P-J Lu, M-S Huang, Michael Hsiao

    Опубліковано 2013
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

    Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized tri... за авторством Qing Zhou, Ying Cheng, Jin‐Ji Yang, Mingfang Zhao, L. Zhang, X.-C. Zhang, Zhendong Chen, Hong‐Hong Yan, Yong Song, Juxiang Chen, Weineng Feng, Chong‐Rui Xu, Z. Wang, H.-J. Chen, Wen‐Zhao Zhong, Y.-P. Liu, Yi‐Long Wu

    Опубліковано 2014
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    Switching to coformulated rilpivirine (<scp>RPV</scp>), emtricitabine (<scp>FTC</scp>) and tenofovir alafenamide from either <scp>RPV</scp>,<scp> FTC</scp> and tenofovir disoproxil fumarate (<scp>TDF</scp>) or efavirenz, <scp>FTC</scp> and <scp>TDF</scp>: 96‐week results from two randomized clinical trials

    Switching to coformulated rilpivirine (<scp>RPV</scp>), emtricitabine (<scp>FTC</scp>) and tenofovir alafenamide from either <scp>RPV</scp>,<scp> FTC</scp> and tenofovir disoproxil... за авторством D Hagins, Chloe Orkin, ES Daar, Anthony Mills, Cynthia Brinson, E DeJesus, Frank A. Post, Javier O Morales‐Ramirez, Melanie Thompson, Olayemi Osiyemi, Bruce Rashbaum, H‐J Stellbrink, Claudia Martorell, H Liu, Y‐P Liu, Danielle Porter, S. E. Collins, Devi SenGupta, Manika Das

    Опубліковано 2018
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study

    First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open... за авторством Yuankai Shi, L. Wang, Baohui Han, W. Li, Pei-wu Yu, Y.P. Liu, Chunming Ding, Xia Song, Z.Y. Ma, Xiaowen Ren, J. Feng, H. L. Zhang, G. -Y. Chen, Xiaohong Han, Ning Wu, Chia-Yu Yao, Yong Song, S. C. Zhang, Wei Song, X. Q. Liu, Sha Zhao, Yangxuan Lin, X.Q. Ye, K. Li, Yongqian Shu, Lili Ding, F. Tan, Yan Sun

    Опубліковано 2017
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: